European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 
30 Aug 2009

REVERSE: Cardiac Resynchronization Therapy Induces Major Structural and Functional Reverse Remodeling In Mild Heart Failure. 24 month results of the REVERSE trial 

Clinical Trial Update I

 

Topics: Heart Failure (HF)
Session number: 1035-1036
Session title: Cardiac Resynchronization Therapy Induces Major Structural and Functional Reverse Remodeling In Mild Heart Failure. 24 month results of the REVERSE trial
Authors: Ghio, Stephano - Cleland, John


Presenter | see Discussant report

Stephano Ghio

Play presentation webcast

Open presentation slides
Stephano Ghio, FESC (Italy)

List of Authors:
Stefano Ghio, On Behalf of the REVERSE Investigators and Coordinators



Discussant | see Presenter abstract

John Cleland

Play presentation webcast

Open presentation slides
John Cleland, FESC (United Kingdom)


Notes to editor
This congress report accompanies a presentation given at the ESC Congress 2009. Written by the author himself/herself, this report does not necessarily reflect the opinion of the European Society of Cardiology.

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.